Schwartz Jonathan David 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Feb 27, 2025
Insider Transaction Report
Form 4
Schwartz Jonathan David
See Remarks
Transactions
- Sale
Common Stock
2024-08-16$18.50/sh−2,710$50,135→ 166,949 total - Sale
Common Stock
2024-11-21$13.05/sh−3,097$40,416→ 163,852 total - Sale
Common Stock
2025-02-25$10.58/sh−6,532$69,109→ 237,638 total - Sale
Common Stock
2024-05-17$23.35/sh−2,754$64,306→ 169,659 total
Footnotes (3)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- [F2]The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
- [F3]Inclusive of the acquisition of 80,318 RSUs that convert to common stock on a one-for-one basis, as reported on the Reporting Person's Form 4 filed on 02/13/2025.